QGen Health Lab - Generate Molecules Overview

The QGen Health Platform is a powerful drug discovery tool that offers researchers a versatile environment to explore new molecules by analyzing existing drugs.

For example, the platform is currently examining Lopinavir, an antiretroviral drug primarily used to treat HIV/AIDS. By making structural modifications, researchers can achieve several key objectives:

- Enhanced inhibition of the HIV protease enzyme

- Reduced adverse effects by minimizing interactions with non-target proteins

- Improved absorption, distribution, metabolism, and excretion (ADME) properties

.

Additionally, drug repurposing through molecular adjustments to Lopinavir offers a promising pathway for developing new treatments in a cost-effective and efficient manner.

For instance, the combination of Lopinavir and Ritonavir (Kaletra), originally approved for treating HIV, has also been investigated for potential use against other viral infections, including COVID-19.

QGen Health is a robust and versatile platform that provides researchers with all the necessary tools for drug discovery, eliminating the need to leave the platform.

Follow me for more updates.

Social media 🌎: Facebook ⋄ Twitter ⋄ LinkedIn ⋄ Behance